We are live on ! Find out more
KCM

Kendall Capital Management Portfolio holdings

AUM $488M
1-Year Est. Return 28.68%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+28.68%
3 Year Est. Return
+84.44%
5 Year Est. Return
+102.56%
10 Year Est. Return
AUM
$117M
AUM Growth
+$4.26M
Cap. Flow
+$2.33M
Cap. Flow %
1.98%
Top 10 Hldgs %
32.88%
Holding
119
New
11
Increased
44
Reduced
46
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 13.09%
3 Industrials 12.67%
4 Consumer Discretionary 11.64%
5 Financials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCX icon
76
AMC Global Media
AMCX
$501M
$421K 0.36%
6,345
-50
-0.8% -$3.12K
NVS icon
77
Novartis
NVS
$291B
$410K 0.35%
5,312
-2,790
-34% -$206K
DHR icon
78
Danaher
DHR
$137B
$394K 0.34%
4,089
T icon
79
AT&T
T
$160B
$380K 0.32%
+14,994
New +$367K
CODI icon
80
Compass Diversified
CODI
$836M
$374K 0.32%
20,600
+7,125
+53% +$126K
VWO icon
81
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$361K 0.31%
8,804
-2,133
-20% -$89.7K
DBV
82
DELISTED
Invesco DB G10 Currency Harvest Fund
DBV
$361K 0.31%
15,105
-1,298
-8% -$31.4K
BMY icon
83
Bristol-Myers Squibb
BMY
$135B
$360K 0.31%
+5,800
New +$344K
MCO icon
84
Moody's
MCO
$83.8B
$354K 0.3%
2,120
-30
-1% -$5.28K
IJS icon
85
iShares S&P Small-Cap 600 Value ETF
IJS
$8.41B
$347K 0.3%
4,158
-256
-6% -$21.6K
IJK icon
86
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.1B
$345K 0.29%
5,924
-36,852
-86% -$2.14M
TGT icon
87
Target
TGT
$67.3B
$325K 0.28%
3,685
-100
-3% -$8.32K
HBAN icon
88
Huntington Bancshares
HBAN
$35.5B
$324K 0.28%
21,710
+2,110
+11% +$33K
ZD icon
89
Ziff Davis
ZD
$2.04B
$324K 0.28%
4,497
+288
+7% +$21.1K
MCK icon
90
McKesson
MCK
$97.2B
$320K 0.27%
2,410
-165
-6% -$21.5K
QCOM icon
91
Qualcomm
QCOM
$171B
$320K 0.27%
4,440
-2,625
-37% -$173K
OLBK
92
DELISTED
Old Line Bancshares, Inc.
OLBK
$312K 0.27%
9,862
-1,175
-11% -$40.2K
VB icon
93
Vanguard Morningstar Small-Cap ETF
VB
$82.3B
$302K 0.26%
1,860
ADNT icon
94
Adient
ADNT
$1.66B
$295K 0.25%
7,505
-2,166
-22% -$97.6K
AZN icon
95
AstraZeneca
AZN
$241B
$280K 0.24%
3,533
-1,800
-34% -$136K
VZ icon
96
Verizon
VZ
$195B
$277K 0.24%
5,185
-1,994
-28% -$106K
REGN icon
97
Regeneron Pharmaceuticals
REGN
$78.3B
$270K 0.23%
+669
New +$255K
PLNT icon
98
Planet Fitness
PLNT
$4.43B
$249K 0.21%
+4,605
New +$229K
GBX icon
99
The Greenbrier Companies
GBX
$1.56B
$242K 0.21%
4,025
SYK icon
100
Stryker
SYK
$129B
$240K 0.2%
1,350

Similar funds

Kendall Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Kendall Capital Management held 119 positions worth $117M, up 3.8% from $113M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Kendall Capital Management's Q3 2018 filing shows 11 new, 44 increased, 46 reduced and 10 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 8,755 shares worth $965K. The largest sale was iShares S&P Mid-Cap 400 Growth ETF, an estimated $2.14M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Kendall Capital Management's largest Q3 2018 buy was PRA Health Sciences, Inc.: 8,755 shares worth $965K.
  • Kendall Capital Management added most to Vanguard FTSE Europe ETF in Q3 2018, an estimated $684K increase.
  • Kendall Capital Management's biggest Q3 2018 reduction was iShares S&P Mid-Cap 400 Growth ETF, cutting an estimated $2.14M.
  • Kendall Capital Management fully exited SiriusPoint in Q3 2018, selling an estimated $639K.
  • Kendall Capital Management's ten largest holdings make up 33% of its $117M portfolio in Q3 2018.
  • Kendall Capital Management opened 11 new positions and closed 10 in Q3 2018.
  • Kendall Capital Management's portfolio value rose 3.8% quarter-over-quarter to $117M.

Based on Kendall Capital Management's 13F filing for Q3 2018, filed 29 Oct 2018.